entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
101927111,SUCLG2-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,62.3108004934966,-0.239476667225905,0.276256939327158,-0.866862087914122,0.386017578257301,0.940966676272651,NA
101927111,SUCLG2-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,6.18475961513007,-0.321091917143037,0.798435506754269,-0.402151350267865,0.687572643462412,0.96308222060722,patient-derived GBM cell lines (PDGCLs)
101927111,SUCLG2-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,66.9487176242846,-0.00469961440848275,0.261994257374895,-0.0179378527436879,0.985688431743322,0.99673522052731,A549
101927111,SUCLG2-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,57.9093681543172,-0.105567344643033,0.264493360212992,-0.399130415062295,0.689797112436661,0.986418245486816,A549
101927111,SUCLG2-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,47.8393908405719,-2.66060140111356,0.517432914396642,-5.14192531454242,2.71937223707136e-07,1.72656332044747e-06,A549
101927111,SUCLG2-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,32.16595385729,-0.109286631860517,0.32368711023677,-0.337630472157437,0.735641675831474,1,sigmoid colon organoid
101927111,SUCLG2-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,32.16595385729,-0.168621607161348,0.324021439705336,-0.520402623093992,0.602782982208125,1,sigmoid colon organoid
